Listed

Nuvation Bio Inc.

NUVBNYSECIK 1811063HealthcareFiscal year ends Dec 31

Reports and events: 105 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Nuvation Bio Inc., Reports and events
FiledFormWhat it isAccession number
2023-11-2716:01 ET8-K5.02 Departure or appointment of officers or directors0001193125-23-283346
2023-11-1316:11 ET8-K5.02 Departure or appointment of officers or directors0001193125-23-276021
2023-11-0216:23 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-269399
2023-11-0216:21 ET10-QQuarterly reportPeriod 2023-09-300000950170-23-058253
2023-08-0317:30 ET10-QQuarterly reportPeriod 2023-06-300000950170-23-038155
2023-08-0316:17 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-202881
2023-05-1616:03 ET8-K5.07 Shareholder vote results0001193125-23-146073
2023-05-0416:29 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-017926
2023-05-0416:16 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-135935
2023-04-0416:05 ETDEF 14AProxy statementPeriod 2023-05-150001140361-23-016216
2023-03-1516:35 ET10-KAnnual reportPeriod 2022-12-310000950170-23-008180
2023-03-1516:22 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-071350
2023-03-0216:40 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-058263
2023-02-1316:40 ETSC 13D/AOwnership report, active investor, amended0001193125-23-035949
2022-12-2316:26 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-311807
2022-11-0316:38 ET10-QQuarterly reportPeriod 2022-09-300000950170-22-021943
2022-11-0316:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-276899
2022-08-0417:12 ET10-QQuarterly reportPeriod 2022-06-300000950170-22-014868
2022-08-0416:20 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-212548
2022-08-0108:31 ET8-K2.02 Results of operations; 2.05 Exit or disposal costs; 8.01 Other events0001193125-22-207816
2022-05-1716:36 ET8-K5.07 Shareholder vote results0001193125-22-153069
2022-05-0916:33 ET10-QQuarterly reportPeriod 2022-03-310000950170-22-008530
2022-05-0916:22 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-145022
2022-04-0416:01 ETDEF 14AProxy statementPeriod 2022-05-160001140361-22-012878
2022-02-2817:20 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-058273
2022-02-2817:06 ET10-KAnnual reportPeriod 2021-12-310000950170-22-002332
2022-01-1017:09 ET8-K2.02 Results of operations0001193125-22-005788
2022-01-1006:23 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-004997
2021-11-1016:19 ET10-QQuarterly reportPeriod 2021-09-300000950170-21-004093
2021-11-1016:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-325991
2021-10-2816:16 ET8-K1.02 Termination of a material agreement0001193125-21-311319
2021-08-1216:48 ET10-QQuarterly reportPeriod 2021-06-300000950170-21-001385
2021-08-1216:19 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-244709
2021-06-0416:29 ET8-K5.02 Departure or appointment of officers or directors0001193125-21-182967
2021-05-2116:04 ET10-K/AAnnual report, amendedPeriod 2020-12-310001193125-21-169245
2021-05-1717:17 ET10-QQuarterly reportPeriod 2021-03-310000950170-21-000267
2021-05-1717:09 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-163866
2021-05-1416:47 ET8-K4.02 Non-reliance on financial statements0001193125-21-162123
2021-03-2917:07 ETS-1/ARegistration statement, amended0001193125-21-098442
2021-03-1117:16 ET8-K5.02 Departure or appointment of officers or directors0001193125-21-077969
2021-03-1117:07 ETS-1Registration statement0001193125-21-077946
2021-03-1116:59 ET8-K/A9.01 Financial statements and exhibits0001193125-21-077931
2021-03-1116:38 ET10-KAnnual reportPeriod 2020-12-310001193125-21-077880
2021-02-1916:18 ETSC 13DOwnership report, active investor0001193125-21-048965
2021-02-1916:14 ETSC 13DOwnership report, active investor0001193125-21-048950
2021-02-1217:22 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.01 Delisting notice; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.06 Item not in the standard list; 9.01 Financial statements and exhibits0001193125-21-041929
2021-02-0917:20 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001193125-21-034624
2020-11-1610:00 ET10-QQuarterly reportPeriod 2020-09-300001213900-20-037163
2020-10-2109:13 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001213900-20-032470
2020-08-2017:04 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001213900-20-023121

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 4, 2026, 17:21 ET. Listed shows no prices and gives no investment advice.